STAT

Opinion: We don’t need to ban vaping. We need to build better vaping devices

Source: JOSE LUIS MAGANA/AFP via Getty Images

What’s the health care system to do when thousands of individuals, many of them between the ages of 18 and 34, arrive at hospitals across the country with serious, previously unknown breathing problems that may be related to their use of e-cigarettes and vapes? Maybe take a lesson from Hippocrates: First, do no harm.

Reports of this lung problem, now being called e-cigarette or vaping product use associated lung injury (EVALI), began . The Centers for Disease Control and Prevention says that have been reported from every state except Alaska, the District of Columbia, and one U.S. territory; dozens of to using modified equipment, inhaling and, most recently, , a chemical used as an additive or thickening agent in some vaping products.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Wegovy And Ozempic Sales, Rising Pharma Layoffs, And More
Sales of the blockbuster Wegovy obesity treatment more than doubled in the first quarter as Novo Nordisk races to make more of the drug to meet surging demand.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.

Related Books & Audiobooks